Article Text

Veterinary medicines
EMA recommends suspension of drying-off drug

Statistics from

THE European Medicines Agency (EMA) has recommended that the marketing authorisation for the veterinary medicine Velactis (Ceva Santé Animale) should be suspended. The recommendation on July 15 follows reports of adverse events in 319 dairy cows following treatment with the product, which contains the active ingredient cabergoline and was authorised for use as an aid in the abrupt drying-off of dairy cows. The EMA …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.